Trial Profile
Clinical Trials Insight: 700010082
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 08 Dec 2005
Price :
$35
*
At a glance
- Drugs Ombrabulin (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 08 Dec 2005 New trial record.